Synchronous Recto-Sigmoid Colorectal Carcinomas With Microsatellite Instability and an Activating PIK3CA Mutation

被引:1
作者
Mathavan, Mohit [1 ]
Mathavan, Akash [2 ]
Mathavan, Akshay [2 ]
Altshuler, Ellery [2 ]
机构
[1] St Georges Univ, Sch Med, Great River, NY USA
[2] Univ Florida, Gainesville, FL 32611 USA
关键词
synchronous colorectal carcinoma; microsatellite instability; immunotherapy; MISMATCH-REPAIR; COLON-CANCER; FEATURES; BLOCKADE;
D O I
10.1177/23247096221121406
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Synchronous colorectal cancer is a rare subtype of colorectal carcinoma defined by the presence of 2 or more primary tumors simultaneously or within 6 months of initial detection. The overall impact of a synchronous presentation on prognosis is not yet clear. Surgical resection is the primary treatment. However, higher rates of local recurrence and metastasis in synchronous colorectal cancer demand greater exploration of the role of adjuvant therapy. The increased frequency of microsatellite instability observed in synchronous colorectal cancer also affects therapy selection. Similarly, activating PIK3CA mutations are regularly noted in colorectal cancer, but their role in a synchronous presentation has not yet been described. We report a case of a young patient with a synchronous recto-sigmoid colorectal carcinoma complicated by microsatellite instability and an activating PIK3CA mutation-a presentation as of yet unreported in literature. We also review the impact of these molecular events on the efficacy of several chemotherapies and targeted therapies.
引用
收藏
页数:5
相关论文
共 50 条
[31]   Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial [J].
Ogino, Shuji ;
Liao, Xiaoyun ;
Imamura, Yu ;
Yamauchi, Mai ;
McCleary, Nadine J. ;
Ng, Kimmie ;
Niedzwiecki, Donna ;
Saltz, Leonard B. ;
Mayer, Robert J. ;
Whittom, Renaud ;
Hantel, Alexander ;
Benson, Al B., III ;
Mowat, Rex B. ;
Spiegelman, Donna ;
Goldberg, Richard M. ;
Bertagnolli, Monica M. ;
Meyerhardt, Jeffrey A. ;
Fuchs, Charles S. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (23) :1789-1798
[32]   Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases [J].
Baldus, Stephan E. ;
Schaefer, Karl-L. ;
Engers, Rainer ;
Hartleb, Dinah ;
Stoecklein, Nikolas H. ;
Gabbert, Helmut E. .
CLINICAL CANCER RESEARCH, 2010, 16 (03) :790-799
[33]   KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer [J].
De Roock, Wendy ;
De Vriendt, Veerle ;
Normanno, Nicola ;
Ciardiello, Fortunato ;
Tejpar, Sabine .
LANCET ONCOLOGY, 2011, 12 (06) :594-603
[34]   High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases [J].
Brunsell, Tuva Host ;
Sveen, Anita ;
Bjornbeth, Bjorn Atle ;
Rosok, Bard, I ;
Danielsen, Stine Aske ;
Brudvik, Kristoffer Watten ;
Berg, Kaja C. G. ;
Johannessen, Bjarne ;
Cengija, Vanja ;
Abildgaard, Andreas ;
Guren, Marianne Gronlie ;
Nesbakken, Arild ;
Lothe, Ragnhild A. .
CLINICAL COLORECTAL CANCER, 2020, 19 (01) :E26-E47
[35]   PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies [J].
Paleari, L. ;
Puntoni, M. ;
Clavarezza, M. ;
DeCensi, M. ;
Cuzick, J. ;
DeCensi, A. .
CLINICAL ONCOLOGY, 2016, 28 (05) :317-326
[36]   Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer [J].
Bonetti, Luca Reggiani ;
Barresi, Valeria ;
Maiorana, Antonino ;
Manfredini, Samantha ;
Caprera, Cecilia ;
Bettelli, Stefania .
DISEASE MARKERS, 2018, 2018
[37]   Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells [J].
Zumwalt, Timothy J. ;
Wodarz, Dominik ;
Komarova, Natalia L. ;
Toden, Shusuke ;
Turner, Jacob ;
Cardenas, Jacob ;
Burn, John ;
Chan, Andrew T. ;
Boland, C. Richard ;
Goel, Ajay .
CANCER PREVENTION RESEARCH, 2017, 10 (03) :208-218
[38]   Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors [J].
Naguib, Adam ;
Cooke, James C. ;
Happerfield, Lisa ;
Kerr, Lucy ;
Gay, Laura J. ;
Luben, Robert N. ;
Ball, Richard Y. ;
Mitrou, Panagiota N. ;
McTaggart, Alison ;
Arends, Mark J. .
BMC CANCER, 2011, 11
[39]   PIK3CA gene mutations in the helical domain correlate with high tumor mutation buraen and poor prognosis in metastatic breast carcinomas with late-line therapies [J].
Tang, Yu ;
Li, Jing ;
Xie, Ning ;
Yang, Xiaohong ;
Liu, Liping ;
Wu, Hui ;
Tian, Can ;
He, Ying ;
Wang, Xiao ;
He, Qiongzhi ;
Hu, Zhe-Yu ;
Ouyang, Quchang .
AGING-US, 2020, 12 (02) :1577-1590
[40]   PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis [J].
Sarasqueta, Arantza Farina ;
Zeestraten, Eliane C. M. ;
van Wezel, Tom ;
van Lijnschoten, Gesina ;
van Eijk, Ronald ;
Dekker, Jan Willem T. ;
Kuppen, Peter J. K. ;
Goossens-Beumer, Ines J. ;
Lemmens, Valery E. P. P. ;
van de Velde, Cornelis J. H. ;
Rutten, Harm J. T. ;
Morreau, Hans ;
van den Brule, A. J. C. .
CELLULAR ONCOLOGY, 2011, 34 (06) :523-531